J&J | JNJ - Interest Income


J&J reported $2.14 in Interest Income for its fiscal quarter ending in March of 2026.





Interest Income Change Date
AbbVie USD 59M 13M Dec/2025
Abbott USD 78M 1000K Dec/2025
AstraZeneca USD 73M 62M Mar/2026
Baxter International USD 11M 1000K Dec/2025
Bayer EUR 169M 39M Dec/2025
Becton, Dickinson and Co. USD 4M 1000K Dec/2025
Biogen USD 37.9M 700K Mar/2026
Boston Scientific USD 4M 3M Dec/2022
Dexcom USD 23.5M 9.2M Dec/2025
Edwards Lifesciences USD 56.3M 17.7M Dec/2025
Eli Lilly USD 65M 25M Sep/2025
Gilead Sciences USD 95M 7M Dec/2025
GlaxoSmithKline GBP 22M 96M Mar/2026
Globus Medical USD 815K 3.08M Dec/2024
Insulet USD 5.7M 2.9M Dec/2025
Integra LifeSciences USD 4.11M 256K Mar/2026
Intuitive Surgical USD 91.3M 4.2M Dec/2025
J&J USD 2.14 237M Mar/2026
Medtronic USD 114M 23M Jan/2025
Merck USD 69M 27M Dec/2025
Merit Medical Systems USD 3.9M 289K Dec/2025
Pfizer USD 115M 51M Mar/2026
Regeneron Pharmaceuticals USD 193.3M 18.2M Dec/2025
Sanofi EUR 33M 81M Dec/2025
Stryker USD 38M 9M Mar/2025
Tandem Diabetes Care USD 3.02M 507K Dec/2025
Vertex Pharmaceuticals USD 114.8M 7.1M Mar/2026
Zoetis USD 25M 1000K Dec/2025